Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The firm's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The firm is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Follow-Up Questions
AVEFF 股票的价格表现如何？
AVEFF 的当前价格为 $0，在上个交易日 decreased 了 0%。
Avecho Biotechnology Ltd 的主要业务主题或行业是什么？
Avecho Biotechnology Ltd 属于 Pharmaceuticals 行业，该板块是 Health Care
